Healthcare Services Other M&A Deals

VYNE Therapeutics Inc. — SEC S-4/A Filing

Yarrow Bioscience

Apr 28, 2026

Avalo Therapeutics, Inc. — SEC 8-K Filing

Avalo Therapeutics→AlmataBio

Apr 28, 2026

Weight Watchers Announces Actions to Utilize Up to $40 million to Pay Down Debt

WW International

Apr 27, 2026

Eurazeo’s Kurma Partners raises €215m for fourth Biofund

Kurma Partners

Apr 24, 2026

Rallybio Corp — SEC S-4/A Filing

Rallybio→Candid Therapeutics

Apr 24, 2026

IKS Health Announces $557M TruBridge Acquisition Under Regulation 30 - scanx.trade

IKS Health→TruBridge

Apr 23, 2026

IKS Health Announces Agreement to Acquire TruBridge to Strengthen Access to Rural and Community-Based Healthcare - Business Wire

IKS Health→TruBridge

Apr 23, 2026

PE-backed Alcami to acquire Tjoapack

Alcami→Tjoapack

Apr 22, 2026

Veristat, LLC signed a definitive agreement to acquire Regulatory and Medical Writing business of Certara, Inc for approximately $140 million.

Veristat→Certara Regulatory and Medical Writing business

Apr 22, 2026

Merck Moves to Acquire Terns to Strengthen Leukemia Treatment Pipeline - The Healthcare Technology Report.

Merck→Terns

Apr 22, 2026

JATT II Acquisition Corp Announces Closing of $60,000,000 Initial Public Offering

JATT II Acquisition

Apr 20, 2026

Blue Owl Capital to Acquire Health Care REIT Sila Realty Trust in $2.4B Deal

Blue Owl Capital→Sila Realty Trust

Apr 20, 2026

Apposite Capital seals £100m British Business Bank anchor commitment for UK-focused healthtech fund

Apposite Capital

Apr 20, 2026

Piermont Valley Acquisition Corp (CMCAF, CMCUF, CMCWF) — SEC 8-K Filing

Tigerless AI Holdings→Piermont Valley Acquisition

Apr 20, 2026

First Tracks Biotherapeutics, Inc. (TRAX, TRAXV) — SEC 8-K Filing

First Tracks Biotherapeutics

Apr 20, 2026

ANAPTYSBIO, INC (ANAB, ANABV) — SEC 8-K Filing

First Tracks Biotherapeutics

Apr 20, 2026

Kailera’s Upsized IPO Brings In $625M for Pipeline of Injectable & Oral Obesity Drugs

Kailera Therapeutics

Apr 17, 2026

Gilead Receives All Required Regulatory Approvals for the Acquisition of Arcellx and Extends Tender Offer - Business Wire

Gilead→Arcellx

Apr 17, 2026

Panthera Biopartners Expands European Footprint with Acquisition of Hungary’s Leading Clinical Research Organisation OEC - EIN Presswire

Panthera Biopartners→OEC

Apr 17, 2026

JATT II Acquisition Corp Announces Pricing of $60,000,000 Initial Public Offering

Apr 16, 2026